- Report
- March 2024
- 351 Pages
Global
From €5250EUR$5,654USD£4,350GBP
- Report
- August 2023
- 102 Pages
United States
From €5719EUR$5,950USD£4,904GBP
- Report
- January 2020
- 147 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- March 2023
- 115 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- July 2022
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €481EUR$500USD£412GBP
- Report
- January 2019
- 35 Pages
Global
From €961EUR$1,000USD£824GBP
- Report
- July 2023
- 93 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- July 2023
- 99 Pages
Global
From €3500EUR$3,901USD£3,106GBP
The Nuvaring is a medical device used for contraception. It is a flexible, transparent, and hormone-releasing ring that is inserted into the vagina and left in place for three weeks. It is then removed and replaced with a new ring after a one-week break. The Nuvaring is a popular form of contraception due to its convenience and effectiveness.
The Nuvaring market is composed of a variety of companies that manufacture, distribute, and market the device. These companies include Merck, Teva Pharmaceuticals, and Mylan. Additionally, there are a number of pharmacies and online retailers that offer the Nuvaring. These companies provide consumers with access to the device and information about its use. Show Less Read more